1 August 2026 in Research, Society and Development
Background: Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are chronic conditions with a significant impact on quality of life. Regional data on the clinical profile of this population in Santa Catarina, Brazil, remain scarce. Objective: To describe the clinical profile and lifestyle habits of patients with IBD in Santa Catarina and to exploratorily investigate associations between behavioral factors and self-reported disease activity. Methods: Cross-sectional, descriptive study with 165 patients (83 with Crohn's disease, 82 with ulcerative colitis) recruited by convenience sampling via a patient support group and partner institutions, between March and June 2025, using a self-administered electronic questionnaire. Disease activity was estimated using non-validated adaptations of the Harvey–Bradshaw Index and the Mayo Partial Score, with chi-square tests and multivariate logistic regression. Results: There was a female predominance (77.6%) and a higher frequency of patients aged 20–39 years (53.9%), with high educational attainment, consistent with selection bias from digital recruitment. Disease activity was present in 42.1% of Crohn's disease patients and 38.4% of ulcerative colitis patients. Active smoking (OR=2.88), poor sleep quality (OR=2.41), and physical inactivity (OR=1.92) were associated with higher odds of active disease; biologic therapy, with lower odds (OR=0.41). Fistulas predominated in Crohn; arthralgia, in ulcerative colitis. Conclusion: Modifiable behavioral factors were associated with self-reported disease activity. Given the cross-sectional design and non-probabilistic recruitment, these findings should be interpreted as hypothesis-generating rather than causal or representative of the general population of patients with IBD in Santa Catarina.
29 January 2026 in Revista da Faculdade de Ciências Médicas de Sorocaba
Objetivo: avaliar a relação entre atrasos no fornecimento de medicamentos e a qualidade de vida de pacientes com doenças inflamatórias intestinais em Santa Catarina, Brasil. Métodos: estudo transversal retrospectivo com 165 adultos com doença de Crohn (n = 83) e retocolite ulcerativa (n = 82), recrutados entre março e junho de 2025 por meio de instituições de saúde e de grupos virtuais. Dados sociodemográficos, clínicos e terapêuticos foram coletados por meio de um questionário estruturado. A atividade da doença foi avaliada pelos índices de Harvey–Bradshaw e de Mayo Partial Score, e a qualidade de vida, pelos domínios do WHOQOL-BREF. Realizaram-se análises descritivas e de associação (teste do qui-quadrado, ANOVA e regressão logística). Resultados: atrasos no fornecimento de medicamentos ocorreram em 50,9% dos participantes, especialmente na entrega de biológicos. Esses atrasos associaram-se à maior atividade da doença (sangramento intestinal: 48% vs. 22%; p <0,001), complicações graves (fístulas: 38% vs. 18%; p = 0,009) e pior qualidade de vida (OR = 0,48; IC 95% 0,24 – 0,96 para sono inadequado). Conclusão: os resultados indicam que o atraso no fornecimento de medicamentos no âmbito do SUS afeta negativamente o controle clínico e a qualidade de vida de pacientes com DII, evidenciando a necessidade de aprimorar a gestão logística e a equidade no acesso aos insumos terapêuticos.